首页> 外国专利> COMPOSITION FOR DIAGNOSING EARLY HAPATOCELLULAR CARCINOMA OR PROGRSS AND METHOD FOR SCREENINGN ANTICANCER DRUG

COMPOSITION FOR DIAGNOSING EARLY HAPATOCELLULAR CARCINOMA OR PROGRSS AND METHOD FOR SCREENINGN ANTICANCER DRUG

机译:诊断早期肝细胞癌或进展的组合物和筛选抗癌药的方法

摘要

PURPOSE: A composition for diagnosing hepatocellular carcinoma using a gene of which expression is increased or decreases in the hepatocellular carcinoma is provided to early diagnose hepatocellular carcinoma and progress and to monitor prognosis.;CONSTITUTION: A composition for diagnosing hepatocellular carcinoma comprises a material which is able to measure mRNA of RHOB(ras homolog gene family, member B) or PHLDA1(pleckstrin homology-like domain, family A, member 1) and a material which is able to measure protein encoding the genes. The material measuring mRNA is antisense, antisense primer or probe. A method for screening an anticancer drug for hepatocellular carcinoma comprises: a step of culturing cells in which RHOB or PHLDA1 gene is introduced; a step of treating candidate materials which increase or decrease protein expression in the cells; and a step of comparing the expression level with control group expression level.;COPYRIGHT KIPO 2010
机译:目的:提供一种使用在肝细胞癌中表达增加或减少的基因来诊断肝细胞癌的组合物,以早期诊断肝细胞癌和进展并监测预后。;组成:用于诊断肝细胞癌的组合物包含一种能够测量RHOB(ras同源基因家族,成员B)或PHLDA1(pleckstrin同源样结构域,家族A,成员1)的mRNA,以及能够测量编码该基因的蛋白质的材料。测量mRNA的物质是反义,反义引物或探针。一种用于肝癌的抗癌药物的筛选方法,包括:培养导入了RHOB或PHLDA1基因的细胞的步骤;处理增加或减少细胞中蛋白质表达的候选物质的步骤;以及比较表达水平和对照组表达水平的步骤。; COPYRIGHT KIPO 2010

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号